COVID-19: Clinical and Legal Considerations for Reopening

COVID-19: Clinical and Legal Considerations for Reopening

Webinar
Speaking Engagement

As businesses prepare to resume operations, employers face challenges complying with workplace health and safety guidelines. In this webinar, we will cover the legal, clinical and practical guidance for reopening in a responsible manner in this uncertain time.

This webinar will feature a cross-disciplinary panel, including Peggy Otum, a partner at WilmerHale who focuses her practice on complex environmental, health and safety matters, as well as crisis management, including OSHA compliance and enforcement defense; Dr. James Merlino, Chief Clinical Transformation Officer, who oversees the patient experience and enterprise quality and safety at the Cleveland Clinic; and Dr. Richard Waldhorn, a Contributing Scholar at the Johns Hopkins Center for Health Security and a Clinical Professor of Medicine at Georgetown University School of Medicine.

The moderated discussion, led by Partner Alejandro N. Mayorkas, lead of the firm’s Coronavirus (COVID-19) Task Force, will cover three key factors when reopening:

  • Legal requirements, guidance and recommendations;
  • Clinical and medical drivers for the action; and
  • Best practices and practical implementation.

View the Webinar Recording*

*CLE credit is not available for those who watch webinar recordings.

Read More About the Event

Speakers

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.